Stay updated on Pembrolizumab Reirradiation in Glioblastoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Reirradiation in Glioblastoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Reirradiation in Glioblastoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Site revision updated to version v3.5.2, replacing the previous v3.5.0 entry.
    Difference
    0.0%
    Check dated 2026-04-16T10:19:57.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Revision metadata updated: added v3.5.0 and removed v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-25T19:51:29.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3. No visible changes to the study details.
    Difference
    0.0%
    Check dated 2026-03-11T16:52:45.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is shown on the page header/footer. The prior government-funding operating-status notice has been removed, with no changes to the study details.
    Difference
    0.4%
    Check dated 2026-02-11T02:46:52.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    A government funding notice is now displayed and the page shows an updated revision tag (v3.4.1) replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T00:40:51.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Added a glossary toggle (Show glossary) and updated QC labels to 'Last Update Submitted that Met QC Criteria' with a new version tag 'Revision: v3.4.0', while removing the older 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and the previous revision entry. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T00:30:41.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Reirradiation in Glioblastoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Reirradiation in Glioblastoma Clinical Trial page.